Condition: Cardiovascular Risk · Chronic Kidney Disease · Inflammation · Sponsor: Novo Nordisk A/S
This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation. Participants will either get ziltivekimab (active medicine) or placebo (a dummy medicine which has no effect on the body). This is known as the study medicine. Which treatment participants get is decided by chance. Participants chance of getting ziltivekimab or placebo is the same. Ziltivekimab is not yet approved in any country or region in the world. It is a new medicine doctors cannot prescribe. Participants will get the study medicine in a pre filled syringe. Participants will need to use the pre filled syringe to inject the study medicine into a skinfold once-monthly. The study is expected to last for up to 4 years. Participants will have up to 20 clinic visits. Participants will have blood and urine samples taken at most of the clinic visits. Participants will have their heart examined using sound waves (echocardiography) and electrodes (electrocardiogram). Women cannot take part if pregnant, breast-feeding or planning to get pregnant during the study period.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Uni of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| Chambliss Clinical Trials LLC | Montgomery, Alabama, United States | — |
| Lenzmeier Fam Med CCT Research | Glendale, Arizona, United States | — |
| Aventiv Research Inc. | Mesa, Arizona, United States | — |
| Univ of Arkansas Med Sciences | Little Rock, Arkansas, United States | — |
| Unity Health-Searcy Medical Center | Searcy, Arkansas, United States | — |
| National Heart Institute Cal | Beverly Hills, California, United States | — |
| California Inst Of Renal Res | Chula Vista, California, United States | — |
| California Institute of Renal Research #10 | Chula Vista, California, United States | — |
| Valley Clinical Trials | Covina, California, United States | — |
| Valiance Clinical Research | Huntington Park, California, United States | — |
| Scripps Wht Diab Inst La Jolla | La Jolla, California, United States | — |
+ 1059 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.